Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
Open accessThe DOI matches its Crossref record; 82 of the 84 references it cites were found in a registry or an index.
Abstract
Idiopathic pulmonary fibrosis (IPF) is a destructive inflammatory disease with limited therapeutic options. To better understand the inflammatory responses that precede and concur with collagen deposition, we used three models of pulmonary fibrosis and identify a critical mechanistic role for IL-17A. After exposure to bleomycin (BLM), but not Schistosoma mansoni eggs, IL-17A produced by CD4+ and γδ+ T cells induced significant neutrophilia and pulmonary fibrosis. Studies conducted with C57BL/6 il17a−/− mice confirmed an essential role for IL-17A. Mechanistically, using ifnγ−/−, il10−/−, il10−/−il12p40−/−, and il10−/−il17a−/− mice and TGF-β blockade, we demonstrate that IL-17A–driven fibrosis is suppressed by IL-10 and facilitated by IFN-γ and IL-12/23p40. BLM-induced IL-17A production was also TGF-β dependent, and recombinant IL-17A–mediated fibrosis required TGF-β, suggesting cooperative roles for IL-17A and TGF-β in the development of fibrosis. Finally, we show that fibrosis induced by IL-1β, which mimics BLM-induced fibrosis, is also highly dependent on IL-17A. IL-17A and IL-1β were also increased in the bronchoalveolar lavage fluid of patients with IPF. Together, these studies identify a critical role for IL-17A in fibrosis, illustrating the potential utility of targeting IL-17A in the treatment of drug and inflammation-induced fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17A increases and stabilizes TGF-βRII expression on fibroblasts, thereby enhancing their sensitivity to TGF-β120”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [120]
In the citing paper
“the functions of IL-17 include stimulation of ECM production, collagen disposition, and mediation of TGF-β signaling (144).”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [144]
In the citing paper
“murine studies in which administration of IL-17A is sufficient to induce collagen accumulation and fibrotic lesions (144, 145)”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [144]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 6×
“More recently, studies have also suggested important inflammatory activities for TGF, with TGF providing an integral differentiation signal for the develop ment of proinflammatory IL17A–secreting cells (Bettelli et al., 2006; Veldhoen et al., 2006).”
BackgroundResultInfluentialCellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Self-citationIL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 5×
“These observations also suggest that IL10 inhibits the development of BLMinduced fibrosis by targeting the proinflammatory IL23–IL17A pathway rather than the IL12–IFN axis.”
BackgroundInfluentialVeldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605 · cited 3×
“However, recent studies demonstrated that TGF is also critically involved in the development of IL17A–producing lymphocytes (Bettelli et al., 2006; Veldhoen et al., 2006), which regulate the development of a variety of inflammatory and autoimmune diseases (Tesmer et al., 2008).”
BackgroundSutton, C. E., Lalor, S. J., Sweeney, C. M., Brereton, C. F., Lavelle, E. C., & Mills, K. H. G. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.001 · Cited by 1,553 · cited 3×
“Similarly, IL1 can stimulate IL17A production (Sutton et al., 2009), and IL1 is a critical mediator of pulmonary fibrosis (Gasse et al., 2007).”
BackgroundMcGeachy, M. J., Bak-Jensen, K. S., Chen, Y., Tato, C. M., Blumenschein, W., McClanahan, T., & Cua, D. J. (2007) · Nature Immunology · doi:10.1038/ni1539 · Cited by 1,520 · cited 3×
“Similar to previ ous studies (McGeachy et al., 2007; Stumhofer et al., 2007), IL10 was often coexpressed with IL17A and RoRt, sug gesting that Th17 cells may develop into IL10–secreting cells to limit Th17 effector function.”
ResultInduction and effector functions of TH17 cells
Bettelli, E., Korn, T., Oukka, M., & Kuchroo, V. K. (2008) · Nature · doi:10.1038/nature07036 · Cited by 1,216 · cited 2×
“, 2006), which regulate the pathogenesis of a variety of autoimmune and inflammatory diseases (Bettelli et al., 2008).”
BackgroundTesmer, L. A., Lundy, S. K., Sarkar, S., & Fox, D. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00628.x · Cited by 1,102
Nakae, S., Komiyama, Y., Nambu, A., Sudo, K., Iwase, M., Homma, I., Sekikawa, K., Asano, M., & Iwakura, Y. (2002) · Immunity · doi:10.1016/s1074-7613(02)00391-6 · Cited by 1,052 · cited 1×
“However, IL17A has been implicated in IL13– associated airway hyperreactivity (Nakae et al., 2002).”
BackgroundOrtiz, L. A., DuTreil, M., Fattman, C., Pandey, A. C., Torres, G., Go, K., & Phinney, D. G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704421104 · Cited by 1,019 · cited 1×
“These observations are consistent with studies that suggested IL10 could regulate the magnitude and effec tor function of Th17 responses (Fitzgerald et al., 2007; McGeachy et al., 2007; Chang et al., 2008).”
Result
Cited by
Items 201–300 of 751
Protective effect of gallic acid against bleomycin-induced pulmonary fibrosis in rats
Nikbakht, J., Hemmati, A. A., Arzi, A., Mansouri, M. T., Rezaie, A., & Ghafourian, M. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.03.012 · Cited by 67
Th17 can regulate silica‐induced lung inflammation through an IL‐1β‐dependent mechanism
Song, L., Weng, D., Dai, W., Tang, W., Chen, S., Li, C. R., Chen, Y., Liu, F., & Chen, J. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12341 · Cited by 68
“Previous research has demonstrated that IL-1b mediates lung inflammation and that fibrosis is IL-17 dependent [48].”
BackgroundThe importance of extracellular matrix for cell function and in vivo likeness
Hansen, N. U. B., Genovese, F., Leeming, D. J., & Karsdal, M. A. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.01.006 · Cited by 68
Comeglio, P., Filippi, S., Sarchielli, E., Morelli, A., Cellai, I., Corcetto, F., Corno, C., Maneschi, E., Pini, A., Adorini, L., et al. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.01.010 · Cited by 66
Therapeutic Targeting of the Interleukin-4/Interleukin-13 Signaling Pathway: In Allergy and Beyond
Karo‐Atar, D., Bitton, A., Benhar, I., & Munitz, A. (2018) · BioDrugs · doi:10.1007/s40259-018-0280-7 · Cited by 67
The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis
Artlett, C. M. (2022) · Biomolecules · doi:10.3390/biom12050634 · Cited by 64
Acute adaptive immune response correlates with late radiation-induced pulmonary fibrosis in mice
Paun, A., Kunwar, A., & Haston, C. K. (2015) · Radiation Oncology · doi:10.1186/s13014-015-0359-y · Cited by 67
“Il17 and Ifnγ have been reported to exert opposing effects on the development of pulmonary fibrosis [50-53] and a predictive model based on their interaction supports the paradigm that fibrotic lung disease is the result of the synergy between various immune cell types and their cytokine repertoires [54].”
BackgroundHonzawa, Y., Nakase, H., Shiokawa, M., Yoshino, T., Imaeda, H., Matsuura, M., Kodama, Y., Ikeuchi, H., Andoh, A., Sakai, Y., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305632 · Cited by 63
Xiao, F., Liu, X., & Guo, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.610963 · Cited by 67
Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis
Chackelevicius, C. M., Gambaro, S. E., Tiribelli, C., & Rosso, N. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i41.9096 · Cited by 57
Wang, T., Liu, Y., Zou, J., & Cheng, Z. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183972 · Cited by 72
Cai, M., Bonella, F., Dai, H., Sarrı́a, R., Guzman, J., & Costabel, U. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.10.014 · Cited by 60
Role of IL-17A in murine models of COPD airway disease
Yanagisawa, H., Hashimoto, M., Minagawa, S., Takasaka, N., Ma, R., Moermans, C., Ito, S., Araya, J., Budelsky, A., Goodsell, A., et al. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00301.2016 · Cited by 61
“The fibroinflammatory role that we have found for IL-17A and its receptor IL-17RA in murine airway fibrosis is consistent with other studies which have identified roles for IL-17A and IL-17RA, in other fibrotic lung disease models (65).”
BackgroundResultInfluentialTherapeutic pro-fibrogenic signaling pathways in fibroblasts
Cannito, S., Novo, E., & Parola, M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.017 · Cited by 62
“Of interest, upregulation of IL-17A and then the TH17 - related response has been shown to be upstream mechanistically related to the proinflammatory cytokines IL-1β and IL-23 [66,72] and is known to linked also to TGF-β1.”
BackgroundInterleukin-22 Inhibits Bleomycin-Induced Pulmonary Fibrosis
Liang, M., Wang, J., Chu, H., Zhu, X., He, H., Liu, Q., Qiu, J., Zhou, X., Guan, M., Xue, Y., et al. (2013) · Mediators of Inflammation · doi:10.1155/2013/209179 · Cited by 59
Prostatic Inflammation Induces Fibrosis in a Mouse Model of Chronic Bacterial Infection
Wong, L., Hutson, P. R., & BUSHMAN, W. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100770 · Cited by 61
Interleukin 17 Receptor A Modulates Monocyte Subsets and Macrophage Generation In Vivo
Ge, S., Hertel, B., Susnik, N., Rong, S., Dittrich, A., Schmitt, R., Haller, H. G., & von Vietinghoff, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085461 · Cited by 62
Regulatory macrophages as therapeutic targets and therapeutic agents in solid organ transplantation
Broichhausen, C., Riquelme, P., Geissler, E. K., & Hutchinson, J. A. (2012) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e328355a979 · Cited by 58
Apigenin protects against bleomycin-induced lung fibrosis in rats
Chen, L., & Zhao, W. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2885 · Cited by 63
The Th1/Th17 balance dictates the fibrosis response in murine radiation-induced lung disease
Paun, A., Bergeron, M.-E., & Haston, C. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-11656-5 · Cited by 59
Mucins as a New Frontier in Pulmonary Fibrosis
Ballester, B., Milara, J., & Cortijo, J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091447 · Cited by 67
Pulmonary toxicants and fibrosis: innate and adaptive immune mechanisms
Malaviya, R., Kipen, H. M., Businaro, R., Laskin, J. D., & Laskin, D. L. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115272 · Cited by 59
Akbar, M., Crowe, L. A. N., McLean, M., Melchor, E. G., MacDonald, L., Carter, K. A., Fazzi, U. G., Martin, D. P., Arthur, A., Reilly, J. H., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102715118 · Cited by 64
“We found that both CD4+ and CD8+ T cells from frozen shoulder tissue were able to produce IL17A following stimulation and intracellular staining (Fig.”
BackgroundInfluentialVittal, R., Fisher, A. J., Gu, H., Mickler, E. A., Panitch, A., Lander, C., Cummings, O. W., Sandusky, G. E., & Wilkes, D. S. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0389oc · Cited by 60
“of inhibitory SMADs and IL-1b To investigate further the mechanisms underlying the MK2i “rescue” of fibrotic lung tissue, a fibrosis-specific 80-gene PCR array was used to analyze mRNA expression in the bleomycin model of established fibrosis (Figure E2).”
BackgroundInfluentialRole of Complement Activation in Obliterative Bronchiolitis Post–Lung Transplantation
Suzuki, H., Lasbury, M. E., Fan, L., Vittal, R., Mickler, E. A., Benson, H. L., Shilling, R. A., Wu, Q., Weber, D. J., Wagner, S. R., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202242 · Cited by 56
“Alternatively, any preexisting condition that increases IL-17 levels, such as ischemia reperfusion injury (37) or idiopathic pulmonary fibrosis (47), could downregulate CRPs on airway epithelium of newly transplanted donor lung, as described above.”
BackgroundRole of sirtuins in chronic obstructive pulmonary disease
Chun, P. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0494-2 · Cited by 57
“The role of IL-1b and TGF-b in idiopathic pulmonary fibrosis (IPF) pathogenesis has been well established (Sime et al. 1997; Wilson et al. 2010).”
Interleukin-17 Drives Interstitial Entrapment of Tissue Lipoproteins in Experimental Psoriasis
Huang, L.-H., Zinselmeyer, B. H., Chang, C.-H., Saunders, B. T., Elvington, A., Baba, O., Broekelmann, T. J., Qi, L., Rueve, J. S., Swartz, M. A., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.10.006 · Cited by 54
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript Also, IL-17A levels in humans correlate with the extent of vascular collagen and TGFβ signaling in T cells mediated atherosclerotic plaque fibrosis by inducing IL-17A that was served as a required mediator for collagen accumulation (Gister…”
BackgroundInfluentialYin, Q., Pi, X., Jiang, Y., Ren, G., Liu, Z., Liu, H., Wang, M., Sun, W., Li, S., Gao, Z., et al. (2021) · Inflammation · doi:10.1007/s10753-021-01449-4 · Cited by 61
“It has been shown that IL-1β mediated fibrosis is similar to BLM-induced lung fibrosis models as both are highly dependent on IL-17A [38].”
BackgroundMishra, N. C., Rir-sima-ah, J., Grotendorst, G. R., Langley, R. J., Singh, S. P., Gundavarapu, S., Weber, W., Peña-Philippides, J. C., Duncan, M. R., & Sopori, M. L. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.03.010 · Cited by 55
“IL-17 cells have been implicated in a number of autoimmune and experimental fibrotic lung diseases, including cystic fibrosis [66], sarcoidosis [67], systemic sclerosis-related pulmonary fibrosis [68], and bleomycin-induced lung fibrosis [69].”
The Triterpenoid CDDO-Me Inhibits Bleomycin-Induced Lung Inflammation and Fibrosis
Kulkarni, A. A., Thatcher, T. H., Hsiao, H.-M., Olsen, K. C., Kottmann, R. M., Morrissette, J., Wright, T. W., Phipps, R. P., & Sime, P. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063798 · Cited by 59
“TGFb is a key profibrotic cytokine that drives differentiation of lung fibroblasts to myofibroblasts [1,38,39]; TGFb has also been shown to upregulate IL-17A which promotes fibrosis in multiple models [40,41].”
BackgroundTreatment of orbital vascular malformations with intralesional injection of pingyangmycin
Yue, H., Jiang, Q., Elner, V. M., Guo, J., Yuan, Y.-F., Zhang, R., & Ge, Q. (2013) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2012-302900 · Cited by 55
IL-17 and CD40 ligand synergistically stimulate the chronicity of diabetic nephropathy
Kuo, H., Huang, C., Lin, T., & Lin, C. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw397 · Cited by 58
Tregs Promote the Differentiation of Th17 Cells in Silica-Induced Lung Fibrosis in Mice
Song, L., Weng, D., Liu, F., Chen, Y., Li, C., Dong, L., Tang, W., & Chen, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037286 · Cited by 55
“The pivotal function of IL-1b and NALP3 inflammasome in the development of lung fibrosis had been proved before [47–50].”
BackgroundIL-17 Promotes Scar Formation by Inducing Macrophage Infiltration
Zhang, J., Qiao, Q., Liu, M., He, T., Shi, J., Bai, X., Zhang, Y., Li, Y., Cai, W., Han, S., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.04.005 · Cited by 62
Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis
Ma, H., Liu, S., Li, S., & Xia, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.918771 · Cited by 63
Akram, K. M., Lomas, N. J., Forsyth, N. R., & Spiteri, M. A. (2014) · Europe PMC (PubMed Central) · Cited by 65
IL-17A/F Modulates Fibrocyte Functions in Cooperation with CD40-Mediated Signaling
Hayashi, H., Kawakita, A., Okazaki, S., Yasutomi, M., Murai, H., & Ohshima, Y. (2013) · Inflammation · doi:10.1007/s10753-013-9609-z · Cited by 55
Tang, H., He, H., Ji, H. L., Gao, L., Mao, J., Liu, J., Lin, H., & Wu, T. (2015) · Journal of Surgical Research · doi:10.1016/j.jss.2015.02.062 · Cited by 53
Single-Cell Analysis Reveals Novel Immune Perturbations in Fibrotic Hypersensitivity Pneumonitis
Zhao, A., Unterman, A., Hussein, N. S. A., Sharma, P., Nikola, F., Flint, J., Yan, X., Adams, T. S., Justet, A., Sumida, T. S., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202401-0078oc · Cited by 56
Uncoupling between Inflammatory and Fibrotic Responses to Silica: Evidence from MyD88 Knockout Mice
Re, S. L., Yakoub, Y., Devosse, R., Uwambayinema, F., Couillin, I., Ryffel, B., Marbaix, É., Lison, D., & Huaux, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099383 · Cited by 53
“In particular, it has been shown that immunosuppressive Foxp3-expressing regulatory T lymphocytes (T regs) [33] and inflammatory IL-17A-producing T lymphocytes (Th17) [34] can drive a pulmonary fibrotic process in humans and animals.”
BackgroundLi, H., Yu, H., Zhang, H., Ying, W., Li, D., Ge, Y., Ying, B., Cheng, B., Lian, Q., & Jin, S. (2017) · Scientific Reports · doi:10.1038/srep46754 · Cited by 58
Cui, Y., Xin, H., Tao, Y., Mei, L., & Wang, Z. (2020) · Phytotherapy Research · doi:10.1002/ptr.6857 · Cited by 52
“IL-1 beta indirectly promotes the production of fibrosis by regulating the expression of IL-17 (Wilson et al., 2010), and this factor can promote the production of fibrosis in liver, kidney and lung (Gieling, Wallace, & Han, 2009; Guo et al., 2013; Jones et al., 2009).”
BackgroundA comprehensive network map of IL-17A signaling pathway
Balaya, R. D. A., Dagamajalu, S., Gouda, M. M., Suchitha, G. P., Chanderasekaran, J., Raju, R., Prasad, T. S. K., & Bhandary, Y. P. (2022) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-022-00686-y · Cited by 57
Liu, Q., Bi, Y., Song, S., Zhu, K., Qiao, X., Wang, H., & Ji, G. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03449-7 · Cited by 53
“Studies have demonstrated that BLM induces oxidative damage and DNA strand break-age, with early pathological manifestations of exudative alveolitis, generation of inflammation, late pathological manifestations of stromal cell proliferation, and matrix collagen aggregation [10, 11].”
BackgroundNikota, J. K., Banville, A. C., Goodwin, L. R., Wu, D., Williams, A., Yauk, C. L., Wallin, H., Vogel, U. B., & Halappanavar, S. S. (2017) · Particle and Fibre Toxicology · doi:10.1186/s12989-017-0218-0 · Cited by 53
“For example, targeting inflammatory mediators such as IL-17A reduced the number of fibrotic lesions in mice exposed to the lungdamaging peptide bleomycin or fibrosis-inducing bacteria [9, 10].”
BackgroundKim, M., Kim, S. H., Jeon, D., Kim, H.-Y., & Lee, K. (2017) · Toxicology · doi:10.1016/j.tox.2017.11.017 · Cited by 51
Regulatory T cells are a double-edged sword in pulmonary fibrosis
Wang, F., Xia, H., & Yao, S. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106443 · Cited by 57
Kass, D. J., Yu, G., Loh, K. S., Savir, A., Borczuk, A., Kahloon, R., Juan-Guardela, B., Deiuliis, G., Tedrow, J., Choi, J., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.01.010 · Cited by 51
Ray, D., Nelson, T. A., Fu, C., Patel, S., Gong, D. N., Odegaard, J. I., & Hsieh, M. H. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001912 · Cited by 53
“mansoni egginduced, synchronous lung granuloma model [40,41].”
Ray, S., De Salvo, C., & Pizarro, T. T. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000119 · Cited by 49
“mice show reduced fibrosis in inflammatory skin models [23] and IL-17A is essential to fibrogenesis in pulmonary fibrosis models [8].”
BackgroundSzóstek-Mioduchowska, A. Z., Bacławska, A., Okuda, K., & Skarzynski, D. J. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154767 · Cited by 52
Fei, Y.-X., Zhao, B., Yin, Q., Qiu, Y.-Y., Ren, G., Wang, B., Wang, Y.-F., Fang, W., & Li, Y. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01361 · Cited by 52
“Inflammatory factors contribute to the development of lung injury, among which TNF-α, IL-1β and IL-6 are the major cytokines (Quay et al., 1998; Smith et al., 1998; Koksoy et al., 2001; Goodman et al., 2003; Saito et al., 2008; Wilson et al., 2010; Pedroza et al., 2011; Patel et al., 2013).”
BackgroundA protective role for IL-13 receptor α 1 in bleomycin-induced pulmonary injury and repair
Karo‐Atar, D., Bordowitz, A., Wand, O., Pasmanik‐Chor, M., Fernandez, I. E., Itan, M., Frenkel, R., Herbert, D. R., Finkelman, F. D., Eickelberg, O., et al. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.56 · Cited by 51
“The undisputed findings regarding the pro-fibrotic function of IL-13 in combination with our data using bleomycin-treated Il13ra1 / mice strengthen the notion that increased fibrotic pathology in Il13ra1 / mice is likely due to a ‘‘homeostatic’’ defect and that injury-induced IL-13 has a minor role in the bleomycin mo…”
BackgroundResultInfluentialL-plastin enhances NLRP3 inflammasome assembly and bleomycin-induced lung fibrosis
Joshi, H. P., Almgren‐Bell, A., Anaya, E. P., Todd, E. M., Dyken, S. J. V., Seth, A., McIntire, K. M., Singamaneni, S., Sutterwala, F. S., & Morley, S. C. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110507 · Cited by 55
“Bleomycin directly injures lung epithelium, promoting uric acid production and triggering NLRP3 assembly; the resulting IL-1β production initiates an inflammatory response that further damages the tissue (Wilson et al., 2010).”
BackgroundBiomarkers in idiopathic pulmonary fibrosis: Current insight and future direction
Zheng, Z., Peng, F., & Zhou, Y. (2024) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2024.04.003 · Cited by 56
Lack of IL-17 signaling decreases liver fibrosis in murine schistosomiasis japonica
Zhang, Y., Huang, D., Gao, W., Yan, J., Zhou, W., Hou, X., Liu, M., Ren, C., Wang, S., & Shen, J. (2015) · International Immunology · doi:10.1093/intimm/dxv017 · Cited by 46
The role of adipokines in systemic sclerosis: a missing link?
Żółkiewicz, J., Stochmal, A., & Rudnicka, L. (2019) · Archives of Dermatological Research · doi:10.1007/s00403-019-01893-1 · Cited by 53
“IL-17 retains pro-fibrotic state of various cells, impacts differentiation of fibroblasts, inhibits autophagy and exacerbates overall inflammatory status, implicating its role in the pathogenesis of SSc [54, 64, 114, 121].”
BackgroundRoles of IL‐17, Th1, and Tc1 cells in patients with IgG4‐related sclerosing sialadenitis
Ohta, N., Makihara, S., Okano, M., Kurakami, K., Ishida, A., Furukawa, T., Suzuki, Y., Watanabe, T., Kakehata, S., & Aoyagi, M. (2012) · The Laryngoscope · doi:10.1002/lary.23429 · Cited by 54
Repetitive intradermal bleomycin injections evoke T-helper cell 2 cytokine-driven pulmonary fibrosis
Singh, B., Kasam, R. K., Sontake, V., Wynn, T. A., & Madala, S. K. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00184.2017 · Cited by 48
“using BCA kit, and 25 μg/lane of tissue lysates were loaded on 10% Gelatin Zymogram 185 Gels (Invitrogen) (42).”
BackgroundMethodSelf-citationZhang, X.-W., Mi, S., Li, Z., Zhou, J.-C., Xie, J., Hua, F., Li, K., Cui, B., Lv, X.-X., Yu, J.-J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14266 · Cited by 48
“We and others demonstrated that bleomycin induces pulmonary fibrosis in an IL-17A dependent manner [9, 10].”
BackgroundLonati, P. A., Brembilla, N. C., Montanari, E., Fontao, L., Gabrielli, A., Vettori, S., Valentini, G., Laffitte, E., Kaya, G., Meroni, P. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105008 · Cited by 53
Plasma membrane wounding and repair in pulmonary diseases
Cong, X., Hubmayr, R. D., Li, C., & Zhao, X. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00486.2016 · Cited by 49
Role of interleukin 17 in TGF-β signaling-mediated renal interstitial fibrosis
Sun, B., Wang, H., Zhang, L., Yang, X., Zhang, M., Zhu, X., Ji, X., & Wang, H. (2018) · Cytokine · doi:10.1016/j.cyto.2017.10.015 · Cited by 47
Bruggen, S. V., & Martinod, K. (2022) · Immunological Reviews · doi:10.1111/imr.13179 · Cited by 54
Kim, H. S., Go, H., Akira, S., & Chung, D. H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101654 · Cited by 47
“In contrast, in a recent study, IL-17A produced by CD4 and gd T cells promoted bleomycin and IL-1b–mediated pulmonary fibrosis (42).”
ResultProstaglandin I2 analogues enhance already exuberant Th17 cell responses in systemic sclerosis
Truchetet, M., Allanore, Y., Montanari, E., Chizzolini, C., & Brembilla, N. C. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201400 · Cited by 47
Shi, T., Zhang, T., Zhang, L., Yang, Y., Zhang, H., & Zhang, F. (2015) · Medicine · doi:10.1097/md.0000000000001888 · Cited by 48
“For example, in bleomycininduced idiopathic pulmonary fibrosis, early IL-17 production was essential during late fibrosis.(14,37) In addition, IL-17 can lead to myocardial fibrosis in an isoproterenol-induced heart failure model.”
BackgroundNaringenin Ameliorates Radiation-Induced Lung Injury by Lowering IL-1β Level
Zhang, C., Zeng, W., Yao, Y., Xu, B., Wei, X., Wang, L., Yin, X., Barman, A. K., Zhang, F., Zhang, C., et al. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.248807 · Cited by 47
“…aeruginosa, bleomycin, or irradiation can induce lung fibrosis, during which inflammasome is activated, indicating involvement of an IL-1 family member in the pathogenesis of lung fibrosis (Gasse et al., 2007; Wilson et al., 2010; Palomo et al., 2014; Sun et al., 2015; Zhang et al., 2016b).”
BackgroundInfluentialBiancatelli, R. M. L. C., Solopov, P. A., & Catravas, J. D. (2022) · American Journal Of Pathology · doi:10.1016/j.ajpath.2022.03.003 · Cited by 48
Pingyangmycin as First-Line Treatment for Low-Flow Orbital or Periorbital Venous Malformations
Jia, R., Xu, S., Huang, X., Song, X., Pan, H., Zhang, L., He, F., Lin, M., Ge, S., & Fan, X. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.8229 · Cited by 47
The role of the acquired immune response in systemic sclerosis
Chizzolini, C., & Boin, F. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0509-1 · Cited by 52
“In animal models, IL17A does mediate fibrosis and SSc-like manifestations, as shown in the lungs and skin of the bleomycin as well as tight skin-1 (TSK-1/+) mice [37, 74, 79, 115].”
BackgroundThe Role of T Lymphocytes in Cutaneous Scarring
Short, W. D., Wang, X., & Keswani, S. G. (2021) · Advances in Wound Care · doi:10.1089/wound.2021.0059 · Cited by 49
“Th17s are defined by their production of IL-17, which contributes to skin and lung fibrosis in bleomycin mouse models.(49,50) In humans, IL-17 enhances fibroblast proliferation and their secretion of inflammatory cytokines, MCP-1, IL-6, and IL-8, while also increasing levels of matrix metalloproteinase-1 and -3.”
BackgroundAdegunsoye, A., Hrusch, C. L., Bonham, C. A., Jaffrey, M. R., Blaine, K. M., Sullivan, M., Churpek, M. M., Strek, M. E., Noth, I., & Sperling, A. I. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00516 · Cited by 48
“As IL-17 is associated with human airway neutrophil recruitment (49), and BAL neutrophilia predicts early mortality in IPF (50), our findings of decreased CCR6+ CD4+ T cells in the lungs may protect from detrimental neutrophilia.”
BackgroundInfluentialChronic intermittent hypoxia worsens bleomycin-induced lung fibrosis in rats
Braun, R., Broytman, O., Braun, F., Brinkman, J. A., Clithero, A. D., Modi, D., Pegelow, D. F., ELDRIDGE, M. W., & Teodorescu, M. (2017) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2017.04.010 · Cited by 49
“CIH prolonged IL-17 and CCN-2 gene expression IL-17 has been strongly associated with the detrimental effects of Blm in the rodent lungs (Gasse et al., 2011; Wilson et al., 2010).”
BackgroundRegulatory T Cells: An Emerging Player in Radiation-Induced Lung Injury
Guo, T., Zou, L., Ni, J., Zhou, Y., Ye, L., Yang, X., & Zhu, Z.-F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01769 · Cited by 48
The mechanism of gut-lung axis in pulmonary fibrosis
Dong, Y., He, L., Zhu, Z., Yang, F., Ma, Q., Zhang, Y., Zhang, X., & Liu, X. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1258246 · Cited by 52
New Insights into the Mechanisms of Innate Immune Receptor Signalling in Fibrosis
Lafyatis, R., & Farina, G. A. (2012) · The Open Rheumatology Journal · doi:10.2174/1874312901206010072 · Cited by 49
“This latter model of lung fibrosis involves IL-17 production, withTGF- possibly playing a key role upstream of IL17 in TH17 cell polarization and/or in mediating the pro-fibrotic effects of IL-17[82, 83].”
BackgroundThe role of halofuginone in fibrosis: more to be explored?
Luo, Y., Xie, X., Luo, D., Wang, Y., & Gao, Y. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ru0417-148rr · Cited by 47
“has been implicated in the pathogenesis of pulmonary fibrosis [18], chronic allograft rejection [19], fibrosis in orthotopic”
BackgroundIL-17A Dissociates Inflammation from Fibrogenesis in Systemic Sclerosis
Dufour, A. M., Borowczyk, J., Alvarez, M., Truchetet, M., Modarressi, A., Brembilla, N. C., & Chizzolini, C. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.05.026 · Cited by 46
“Murine experiments point to a profibrotic role of IL-17A (Mi et al., 2011; Okamoto et al., 2012; Wilson et al., 2010).”
BackgroundModulation of pulmonary fibrosis by IL-13Rα2
Lumsden, R. V., Worrell, J. C., Boylan, D., Walsh, S. M., Cramton, J., Counihan, I. P., O’Beirne, S. L., Medina, M. F. C., Gauldie, J., Fabre, A., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00120.2014 · Cited by 44
“They suggest that bleomycin-induced pulmonary fibrosis is IL-13 and IL-13R 2 independent (29).”
BackgroundAdegunsoye, A., & Balachandran, J. S. (2015) · Mediators of Inflammation · doi:10.1155/2015/510105 · Cited by 46
Fibrocytes Regulate Wilms Tumor 1–Positive Cell Accumulation in Severe Fibrotic Lung Disease
Sontake, V., Shanmukhappa, S. K., DiPasquale, B. A., Reddy, G. B., Medvedovic, M., Hardie, W. D., White, E. S., & Madala, S. K. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500963 · Cited by 47
Self-citationFava, A., Cimbro, R., Wigley, F. M., Liu, Q., Rosen, A., & Boin, F. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-0993-2 · Cited by 44
“In animal models, IL-17 can drive fibrosis, as shown in the lungs and skin of bleomycin as well as tight-skin-1 (TSK-1/+) mice [36, 37].”
BackgroundYang, G., Lyu, L., Wang, X., Bao, L., Lyu, B., & Lin, Z. (2019) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2019.03.011 · Cited by 47
The Kinase PKCα Selectively Upregulates Interleukin-17A during Th17 Cell Immune Responses
Meisel, M., Hermann‐Kleiter, N., Hinterleitner, R., Gruber, T., Wachowicz, K., Pfeifhofer‐Obermair, C., Fresser, F., Leitges, M., Soldani, C., Viola, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.09.021 · Cited by 47
Icariside Ⅱ attenuates bleomycin-induced pulmonary fibrosis by modulating macrophage polarization
Deng, L., Ouyang, B., Shi, H., Yang, F., Li, S., Xie, C. H., Du, W., Hu, L., Wei, Y., & Dong, J. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116810 · Cited by 44
Krasimirova, E., Velikova, T. V., Ivanova‐Todorova, E., Tumangelova-Yuzeir, K. D., Kalinova, D., Boyadzhieva, V. V., Stoilov, N. R., Yoneva, T., Rashkov, R. K., & Kyurkchiev, D. S. (2017) · World Journal of Experimental Medicine · doi:10.5493/wjem.v7.i3.84 · Cited by 48
Dong, Z., Lu, X., Yang, Y., Zhang, T., Li, Y., Chai, Y., Lei, W., Li, C., Ai, L., & Tai, W. (2015) · BMC Pulmonary Medicine · doi:10.1186/s12890-015-0012-4 · Cited by 42
“with other research [12,13], and they did not explore the”
BackgroundThe Airway Microbiome-IL-17 Axis: a Critical Regulator of Chronic Inflammatory Disease
Mannion, J. M., McLoughlin, R. M., & Lalor, S. J. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-022-08928-y · Cited by 43
“Germ-free or antibiotic-treated mice, as well as mice that are deficient in IL-17A, IL-17B or IL17E/IL-25, are resistant to bleomycin-induced fibrosis [31, 32, 163].”
BackgroundTh17 Down-regulation Is Involved in Reduced Progression of Schistosomiasis Fibrosis in ICOSL KO Mice
Wang, B., Song, L., Wang, Y., Zhu, X.-Q., Gong, W., Zhang, H.-Q., Li, Y., & Xia, C.-M. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003434 · Cited by 45
Obi, A. T., Diaz, J. A., Ballard-Lipka, N., Roelofs, K. J., Farris, D. M., Lawrence, D. A., Wakefield, T. W., & Henke, P. K. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12644 · Cited by 42
Serum concentrations of IL-17A, IL-17B, IL-17E and IL-17F in patients with systemic sclerosis
Robak, E., Gerlicz-Kowalczuk, Z. A., Dziankowska‐Bartkowiak, B., Woźniacka, A. J., & Bogaczewicz, J. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.84738 · Cited by 43
The Possible Pathogenesis of Idiopathic Pulmonary Fibrosis consideringMUC5B
Zhang, Q., Wang, Y., Qu, D., Yu, J., & Yang, J. (2019) · BioMed Research International · doi:10.1155/2019/9712464 · Cited by 51
Natural Product-Based Potential Therapeutic Interventions of Pulmonary Fibrosis
Hasan, M., Paul, N. C., Paul, S. K., Saikat, A. S. M., Akter, H., Mandal, M., & Lee, S. (2022) · Molecules · doi:10.3390/molecules27051481 · Cited by 46
Ji, W., Ma, Y., Zhou, X., Zhang, Y., Lu, R., Guo, Z.-Z., Sun, H.-Y., Hu, D.-C., Yang, G.-H., Li, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081090 · Cited by 45
“The collagen content in the whole left lung was determined by analysis of hydroxyproline as previously described [20] .”
MethodThe role of all-transretinoic acid in bleomycin-induced pulmonary fibrosis in mice
Dong, Z., Tai, W., Yang, Y., Zhang, T., Li, Y., Chai, Y., Zhong, H., Zou, H., & Wang, D. (2012) · Experimental Lung Research · doi:10.3109/01902148.2011.646052 · Cited by 41
“[14] used 3 models of pulmonary fibrosis and identify a critical mechanistic role for IL-17A; their studies identify a critical role for IL-17A in fibrosis, illustrating the potential utility of targeting IL-17A in the treatment of drug- and inflammation-induced fibrosis.”
MethodMyocardial fibrosis seen through the lenses of T-cell biology
Ramos, G. C., Hofmann, U., & Frantz, S. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.01.018 · Cited by 49
Xiong, M., Zhao, Y., Mo, H., Yang, H., Yue, F., & Hu, K. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108165 · Cited by 44
Pin1 Protein Regulates Smad Protein Signaling and Pulmonary Fibrosis
Shen, Z.-J., Braun, R. K., Hu, J., Xie, Q., Chu, H., Love, R. B., Stodola, L. A., Rosenthal, L. A., Szakaly, R. J., Sorkness, R. L., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.313684 · Cited by 42
“Consistent with previous studies (2), BLM-induced injury dramatically increased the expression of type I, III, and V collagen mRNAs and proteins in wild-type mice, which was dramatically attenuated in Pin1 / mice (Fig.”
BackgroundMethodInfluentialPeiminine ameliorates bleomycin-induced acute lung injury in rats
GUO, H., Ji, F.-Z., Liu, B., Chen, X., He, J., Zhao, X., & GONG, J. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1312 · Cited by 44
Metadata
- Authors
- Wilson, M. S., Madala, S. K., Ramalingam, T. R., Gochuico, B. R., Rosas, I. O., Cheever, A. W., & Wynn, T. A.
- Affiliations
- National Institutes of Health (US)
- Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115 3
- Biomedical Research Institute (US)
- Corresponding author
- Wynn, Thomas A.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-02-22
- Volume
- 207
- Issue
- 3
- Pages
- 535-552
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2839145
- OpenAlex
- W2095715691
- Cited by
- 730
- References
- 84
- Citations by year
- 2026: 28 · 2025: 39 · 2024: 68 · 2023: 45 · 2022: 47 · 2021: 39 · 2020: 38 · 2019: 51 · 2018: 47 · 2017: 48 · 2016: 42 · 2015: 42 · 2014: 40 · 2013: 57 · 2012: 45
- FWCI
- 41.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Keywords
- idiopathic pulmonary fibrosis, IL-17A, bleomycin-induced lung injury, IL-1β, pulmonary fibrosis, TGF-beta, IL-10, interferon-gamma, IL-12/23p40, γδ T cells, CD4+ T cells, neutrophilia, Schistosoma mansoni eggs, bronchoalveolar lavage, IL-17A blockade
- MeSH terms
- Animals, Bleomycin, Interferon-gamma, Lung, Male, Mice, Inbred C57BL, Pulmonary Fibrosis, Schistosoma mansoni, Schistosomiasis mansoni, CD4-Positive T-Lymphocytes, Interleukin-10, Mice, Knockout, Interleukin-13, Interleukin-17, Mice, Interleukin-1beta, Interleukin-12 Subunit p40
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.